Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation

ABSTRACT:

SUBMITTER: Liu J 

PROVIDER: S-EPMC12395921 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature